Solanbridge Group, Inc.

$0.00+0.00%(+$0.00)
TickerSpark Score
36/100
Weak
20
Valuation
20
Profitability
20
Growth
20
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLNX research report →

52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00

Companywww.solanbridgegroup.com

Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado.

CEO
David J. Cutler
IPO
2007
HQ
The Woodlands, TX, US

Price Chart

+400.00% · this period
$0.00$0.00$0.00May 19Nov 17May 19

Valuation

Market Cap
$476.00K
P/E
-7.14
P/S
0.00
P/B
-5.31
EV/EBITDA
-7.03
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
118.24%
ROIC
78.71%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-67.75 · -95.46%
EPS
$0.00 · 0.00%
Op Income
$-60
FCF YoY
38.70%

Performance & Tape

52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-7.37
Avg Volume
3

Get TickerSpark's AI analysis on SLNX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our SLNX Coverage

We haven't published any research on SLNX yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate SLNX Report →

Similar Companies